Coya Therapeutics Statistics
NASDAQ: COYAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
4.91+0.06 (+1.24%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Coya Therapeutics by the numbers
Coya Therapeutics has a market capitalization of $115.2 million based on 23.46M shares outstanding. With trailing EPS of $-1.07, Coya Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 4.3% above its 50-day average and 3.8% above its 200-day average.
Average daily trading volume is 167.42K shares, or about $822,037 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
COYA valuation vs. peer median
| Metric | COYA | Peer median | Difference |
|---|---|---|---|
| Market cap | $115.18M | $114.07M | +1% |
| Avg. volume | 167.42K | 715.15K | -77% |
Peer median across 8 companies: GNLX, RANI, PMVP, UNCY, AARD, INO, QUCY, CRBP.
Valuation
- Market cap
- $115.18M
- EPS (TTM)
- $-1.07
- Shares outstanding
- 23.46M
Price and trading
- Previous close
- 4.85
- Open
- 4.81
- Day range
- 4.78 – 5.01
- 52-week range
- 3.71 – 7.75
- 52-week change
- -23.16%
- Beta
- —
- Volume
- 95.51K
- Average volume
- 167.42K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 11, 2026
Additional statistics
- Market Cap
- 115.18M
- Forward Pe
- -2.61
- Eps
- -1.07
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 7.75
- Week52 Low
- 3.71
- Avg Volume
- 167.42K
- Shares Outstanding
- 23.46M
- Ma50
- 4.71
- Ma200
- 4.73
- Earnings Date
- Aug 11, 2026
- Pct From52w High
- -36.65%
- Pct From52w Low
- 32.35%